ArticleBlood cancer journal2022

Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group's clinical trial E3999.

Franck Rapaport et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.